MJ
Minna Jakhar
About Minna Jakhar
Data last updated:
Minna Jakhar is a Director at Ultra Drugs Private Limited (since 2008), Director at Ultra Drugs Formulations Private Limited (since 2020) and Director at Viva Drugs Private Limited (since 2020), and holds 3 more current directorships. The companies operate in Pharma, Information Technology and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹343 Cr; the largest is Ultra Drugs Private Limited at ₹308 Cr (FY 2024). Earlier, Minna Jakhar was a Director at Altar Pharmaceuticals Private Limited (2012–2018) and Director at Ultra Biolabs Private Limited (2011–2013) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jan 2008 | 2005 | ₹308 Cr (FY 2024) | Active | |
| Director | 04 Feb 2020 | 2020 | ₹24.17 Cr (FY 2024) | Active | |
| Director | 17 Jul 2020 | 1996 | ₹10.80 Cr (FY 2025) | Active | |
| Director | 25 May 2015 | 2015 | Active | ||
| Director | 24 Apr 2012 | 2012 | Active | ||
| Director | 08 May 2008 | 2008 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 May 2012 | 2012 | ₹1.24 Cr (FY 2025) | Active | |
| Director | 20 Apr 2011 | 2011 | ₹10.26 Cr (FY 2024) | Active | |
| Director | 08 Feb 2007 | 2007 | Strike Off | ||
| Director | 25 May 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Minna Jakhar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandeep Kumar Arora | 05312136 | Ultra Drugs Private Limited , Ultra Drugs Formulations Private Limited and 2 more | Director |
| Sangram Singh | 01262169 | Ultra Drugs Private Limited , Ultra Drugs Formulations Private Limited and 3 more | Director |
| Sonali Dalla | 07045699 | Viva Drugs Private Limited | Director |
| Malwinderjit Singh Waraich | 06814145 | Apus Life Private Limited | Director |
| Sov Inal Sen | 06740557 | Apus Life Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Minna Jakhar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Minna Jakhar
Minna Jakhar currently holds 6 directorships: Ultra Drugs Private Limited (Director, since 14 Jan 2008, revenue ₹308 Cr (FY 2024)); Ultra Drugs Formulations Private Limited (Director, since 04 Feb 2020, revenue ₹24.17 Cr (FY 2024)); Viva Drugs Private Limited (Director, since 17 Jul 2020, revenue ₹10.80 Cr (FY 2025)); Ultra Bytes Private Limited (Director, since 25 May 2015); Apus Life Private Limited (Director, since 24 Apr 2012); and 1 more.
Minna Jakhar was first appointed on 08 Feb 2007 as Director at Dakhson Formulations Private Limited. The most recent appointment on record is 17 Jul 2020 at Viva Drugs Private Limited.
The 3 current companies of Minna Jakhar that report revenue have a combined latest revenue of ₹343 Cr: Ultra Drugs Private Limited ₹308 Cr (FY 2024); Ultra Drugs Formulations Private Limited ₹24.17 Cr (FY 2024); Viva Drugs Private Limited ₹10.80 Cr (FY 2025).
Minna Jakhar held 4 earlier board appointments: Altar Pharmaceuticals Private Limited (Director, 07 May 2012 to 20 Jun 2018); Ultra Biolabs Private Limited (Director, 20 Apr 2011 to 21 Sep 2013); Dakhson Formulations Private Limited (Director, from 08 Feb 2007); Minson Biosis Private Limited (Director, from 25 May 2007).
The current boards of Minna Jakhar's companies include Sandeep Kumar Arora (Ultra Drugs Private Limited), Sangram Singh (Ultra Drugs Private Limited), Sonali Dalla (Viva Drugs Private Limited), Malwinderjit Singh Waraich (Apus Life Private Limited), Sov Inal Sen (Apus Life Private Limited).